Old Web
English
Sign In
Acemap
>
Paper
>
PIN34 COST-UTILITY ANALYSIS OF DIRECT ACTING ANTIVIRALS FOR EARLY-STAGE GENOTYPE 1 HCV PATIENTS IN BRAZIL
PIN34 COST-UTILITY ANALYSIS OF DIRECT ACTING ANTIVIRALS FOR EARLY-STAGE GENOTYPE 1 HCV PATIENTS IN BRAZIL
2020
Vinicius Lins Ferreira
Bruno Salgado Riveros
Leticia P. Leonart
Maria Lucia Alves Pedroso
M.E. Nita
Roberto Pontarolo
Keywords:
Intensive care medicine
Genotype
Cost–utility analysis
Medicine
DIRECT ACTING ANTIVIRALS
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]